Page last updated: 2024-08-24

telmisartan and Hepatitis

telmisartan has been researched along with Hepatitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cynis, H; Demuth, HU; Fujii, M; Haegele, M; Heiser, U; Hoffmann, T; Kehlen, A; Schilling, S; Shibazaki, Y; Yoneyama, H1

Other Studies

1 other study(ies) available for telmisartan and Hepatitis

ArticleYear
Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice.
    International journal of experimental pathology, 2013, Volume: 94, Issue:3

    Topics: Aminoacyltransferases; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Line, Tumor; Chemokine CCL2; Disease Models, Animal; Enzyme Inhibitors; Fatty Liver; Hepatitis; Human Umbilical Vein Endothelial Cells; Humans; Leukemia, Monocytic, Acute; Macrophages; Mice; Mice, Inbred C57BL; Monocytes; Non-alcoholic Fatty Liver Disease; Telmisartan

2013